A comparison of in vivo gene delivery methods for antisense therapy in ligament healing
暂无分享,去创建一个
T Ochi | C. Frank | N. Shrive | Y. Kaneda | T. Ochi | N. Nakamura | K. Shino | K Shino | N Nakamura | Y Kaneda | DA Hart | T. Ochi | SA Timmermann | NG Shrive | CB Frank | D. Hart | C. Frank | N. Shrive | D. A. Hart | SA Timmermann
[1] M. Aoki,et al. Adenovirus‐mediated gene transfer into tendon and tendon sheath , 1996, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[2] R. Rangayyan,et al. Quantitative analysis of the fine vascular anatomy of articular ligaments , 1992, IEEE Transactions on Biomedical Engineering.
[3] P. Robbins,et al. Gene transfer to the rabbit patellar tendon: potential for genetic enhancement of tendon and ligament healing. , 1996, Gene therapy.
[4] C. Frank. Soft tissue healing , 1994 .
[5] M. Nakanishi,et al. Expression of hepatitis B virus surface antigen in adult rat liver. Co-introduction of DNA and nuclear protein by a simplified liposome method. , 1991, The Journal of biological chemistry.
[6] C. Frank,et al. Rapid isolation of total RNA from small samples of hypocellular, dense connective tissues. , 1997, BioTechniques.
[7] T Ochi,et al. Early biological effect of in vivo gene transfer of platelet-derived growth factor (PDGF)-B into healing patellar ligament , 1998, Gene Therapy.
[8] K. Kaufman,et al. Fate of the ACL-injured Patient , 1994, The American journal of sports medicine.
[9] A. Malmström,et al. Differential expressions of mRNA for proteoglycans, collagens and transforming growth factor-beta in the human cervix during pregnancy and involution. , 1998, Biochimica et biophysica acta.
[10] D. Heinegård,et al. Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. , 1984, The Biochemical journal.
[11] K. Miyasaka. The incidece of knee ligament injuries in the general population , 1991 .
[12] Y. Kaneda,et al. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. , 1993, The Journal of clinical investigation.
[13] T. Ogihara,et al. In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction , 1997, Nature Medicine.
[14] Y. Okada,et al. Expression of hepatitis B virus surface antigen in adult rat liver. Co-introduction of DNA and nuclear protein by a simplified liposome method. , 1991, Journal of Biological Chemistry.
[15] Y. Okada,et al. Modification of cell membranes with viral envelopes during fusion of cells with HVJ (Sendai virus). , 1975, Experimental cell research.
[16] R. Morishita,et al. Characterization of in vivo gene transfer into the arterial wall mediated by the Sendai virus (hemagglutinating virus of Japan) liposomes: an effective tool for the in vivo study of arterial diseases. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[17] C. Frank,et al. Natural history of healing in the repaired medial collateral ligament , 1983, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[18] Y. Kaneda,et al. Fusigenic viral liposome for gene therapy in cardiovascular diseases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[19] P. Scott,et al. Mapping the locations of the epitopes of five monoclonal antibodies to the core protein of dermatan sulfate proteoglycan II (decorin). , 1993, The Journal of biological chemistry.
[20] Thomas A. Mustoe, MD, FACS,et al. Growth factors and wound healing: platelet-derived growth factor as a model cytokine. , 1991, Annual review of medicine.
[21] S L Woo,et al. Medial collateral ligament healing , 1983, The American journal of sports medicine.
[22] Dale M. Daniel,et al. Knee Ligaments: Structure, Function, Injury, and Repair , 1991 .
[23] E. Mekada,et al. Modification of cell membranes with viral envelopes during fusion of cells with HVJ (Sendai virus). III. Effects of mono- and di-saccharides on cell fusion and membrane movement of fused cells. , 1975, Experimental cell research.
[24] C. F. Bennett,et al. Progress in antisense oligonucleotide therapeutics. , 1996, Annual review of pharmacology and toxicology.
[25] Renato V. Iozzo,et al. Targeted Disruption of Decorin Leads to Abnormal Collagen Fibril Morphology and Skin Fragility , 1997, Journal of Cell Biology.
[26] A. Ghahary,et al. Immunohistochemical localization of the proteoglycans decorin, biglycan and versican and transforming growth factor‐β in human post‐burn hypertrophic and mature scars , 1995, Histopathology.
[27] Y. Kaneda,et al. Transient introduction of a foreign gene into healing rat patellar ligament. , 1996, The Journal of clinical investigation.